Brevan Howard Capital Management’s Bausch Health BHC Stock Holding History

Brevan Howard Capital Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,740	Closed	-$137K	–	2154
2025 Q4	$137K	Buy	+19,740	New	+$130K	﹤0.01%	1649
2023 Q1	–	Sell	-195,000	Closed	-$1.22M	–	120
2022 Q4	$1.22M	Buy	195,000 +40,000	+26%	+$279K	0.04%	56
2022 Q3	$1.07M	Buy	+155,000	New	+$1.08M	0.04%	50

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brevan Howard Capital Management's BHC Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 19,740 shares — an estimated $137K sold.

Brevan Howard Capital Management first reported a position in BHC in Q3 2022 and held it in 3 quarters. The position peaked at $1.22M in Q4 2022. 228 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

Brevan Howard Capital Management reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
Brevan Howard Capital Management sold 19,740 Bausch Health shares in Q1 2026, an estimated $137K.
Brevan Howard Capital Management first reported a position in Bausch Health in Q3 2022 and held it in 3 quarters.
Brevan Howard Capital Management's Bausch Health position peaked at $1.22M in Q4 2022.
228 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.